Brendan P. Cormack is a notable inventor based in Santa Cruz, CA. He has made significant contributions to the field of molecular biology, particularly in the development of green fluorescent protein (GFP) mutants. With a total of 4 patents, his work has advanced the understanding and application of fluorescent proteins in various scientific research areas.

Latest Patents

Cormack's latest patents include innovative GFP mutants that have been optimized for fluorescence activation. These mutants, specifically GFPmut1, GFPmut2, and GFPmut3, exhibit single excitation maxima around 488 nm, which are brighter than the wild-type GFP. The specific substitutions in these mutants enhance their fluorescence intensity, making them valuable tools for researchers. Additionally, he has developed a fluorescence-based method for isolating differentially induced genes. This method utilizes regulatory elements activated by stimuli to identify pathogen genes selectively expressed during infection.

Career Highlights

Brendan P. Cormack is affiliated with Leland Stanford Junior University, where he has conducted extensive research in molecular biology. His work has not only contributed to the scientific community but has also paved the way for advancements in genetic research and biotechnology.

Collaborations

Cormack has collaborated with esteemed colleagues such as Stanley Falkow and Raphael H. Valdivia. These collaborations have further enriched his research and have led to significant findings in the field.

Conclusion

Brendan P. Cormack's innovative work in the development of GFP mutants and gene isolation methods has made a lasting impact on molecular biology. His contributions continue to inspire future research and advancements in the field.